We’re thrilled to announce Nimble entered into a definitive agreement to be acquired by AbbVie. At the closing of the proposed transaction, Nimble and its employees will join AbbVie and advance our innovative pipeline of autoimmune oral therapies. https://lnkd.in/e9d7NqH2
Nimble Therapeutics
Biotechnology Research
Madison, Wisconsin 2,908 followers
Lighting the Way to Breakthrough Medicines
About us
Nimble Therapeutics is a biotechnology company dedicated to delivering on the promise of oral peptide therapeutics. Leveraging a paradigm-shifting peptide drug discovery and development engine, Nimble is advancing its internal pipeline and continues to support several partnered programs. The Nimble platform combines massively parallel solid-phase synthesis, unrivaled chemical and structural diversity, sophisticated assays, and powerful machine learning and computational methods.
- Website
-
http://www.nimbletherapeutics.com
External link for Nimble Therapeutics
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Madison, Wisconsin
- Type
- Privately Held
- Founded
- 2019
Locations
-
Primary
Get directions
603 Science Dr
Madison, Wisconsin 53711, US
-
Get directions
2929 Arch St
Philadelphia, Pennsylvania 19104, US
Employees at Nimble Therapeutics
Updates
-
Welcome to Nimble Therapeutics! We are excited to draw on your experience to rapidly advance our pipeline of Oral peptide therapeutics! Joel Barrish, David Brayden, Joel M Gelfand MD MSCE, Luisa Salter-Cid, Tomi Sawyer https://lnkd.in/gCfrxbqt
-
-
Nimble Therapeutics reposted this
Pete Gough and Lauren Goodrich-Berto are presenting at the Peptide Summit in Boston this week. Come meet us and learn more about the progress we are making towards developing Oral Peptides for Immune-mediated diseases.
-
-
Pete Gough and Lauren Goodrich-Berto are presenting at the Peptide Summit in Boston this week. Come meet us and learn more about the progress we are making towards developing Oral Peptides for Immune-mediated diseases.
-
-
Welcome to the Nimble Team, Munir Mosaheb and Shelley Allen !! We are thrilled to leverage your expertise in Philadelphia to advance our pipeline of orally-delivered peptides. https://lnkd.in/gHD8S5_b
Nimble Therapeutics Expands its Drug Discovery Capabilities to Advance Pipeline to the Clinic - Nimble Therapeutics
https://nimbletherapeutics.com
-
We are excited to welcome Daniel Flynn and Brian Cali to the Nimble Board of Directors. Our team is looking forward to working with you to advance our pipeline of oral peptides. https://lnkd.in/gZUyp_Y6
Nimble Therapeutics Adds Peptide Drug Development Expertise to Board of Directors - Nimble Therapeutics
https://nimbletherapeutics.com
-
Nimble Therapeutics has been named a Madison Magazine Best Place to Work for the second year in a row! Our employees are our greatest asset and we all work hard every day to make Nimble Therapeutics a place where everyone can bring their "whole self" to work. https://lnkd.in/gAxabRW7
Best Places To Work 2023
channel3000.com